Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG103 in Overweight or Obesity
NCT05299697Phase 2Unknown
- Sponsor
- CSPC Baike Biopharmaceutical
- Start
- May 2022
- Primary completion
- Jun 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of GX-G6 in obesity, Overweight, sponsored by CSPC Baike Biopharmaceutical. Status: unknown.
02
Drugs
GX-G6
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT05299697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05299697.